| scholarly article | Q13442814 |
| P50 | author | Jatin P Shah | Q40339322 |
| Ian Ganly | Q43115327 | ||
| Salvatore D'Arpa | Q47344841 | ||
| P2093 | author name string | Nancy Lee | |
| David G Pfister | |||
| Snehal G Patel | |||
| Diane L Carlson | |||
| Jennifer Bocker | |||
| Maria Coleman | |||
| P2860 | cites work | Superselective neck dissection after chemoradiation: feasibility based on clinical and pathologic comparisons. | Q53551140 |
| Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy | Q72120615 | ||
| Surgery after organ preservation therapy. Analysis of wound complications | Q72495566 | ||
| Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer | Q73763048 | ||
| Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer | Q74480930 | ||
| Surgical wound complications after intensive chemoradiotherapy for advanced squamous cell carcinoma of the head and neck | Q79562372 | ||
| Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection? | Q80474215 | ||
| N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02 | Q80735772 | ||
| The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease | Q95720910 | ||
| Brain tumour recurrence: brain single-photon emission computerized tomography, PET and proton magnetic resonance spectroscopy | Q33364425 | ||
| Complications from planned, posttreatment neck dissections | Q33597028 | ||
| Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence | Q33658257 | ||
| The effect of neck dissection on quality of life after chemoradiation | Q33735653 | ||
| Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer | Q33853059 | ||
| The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. | Q33988648 | ||
| Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial | Q34749494 | ||
| Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? | Q34971126 | ||
| Planned postradiotherapy neck dissection: Rationale and clinical outcomes | Q36699011 | ||
| Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study | Q36802886 | ||
| Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer. | Q37111438 | ||
| Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck | Q37112380 | ||
| Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era. | Q37129545 | ||
| Imaging of cell proliferation: status and prospects | Q37181529 | ||
| Proliferation imaging to measure early cancer response to targeted therapy | Q37326102 | ||
| Selective neck dissection following adjuvant therapy for advanced head and neck cancer | Q37334234 | ||
| PET monitoring of therapy response in head and neck squamous cell carcinoma | Q37452341 | ||
| Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. | Q40038485 | ||
| Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. | Q41251899 | ||
| Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer | Q44818887 | ||
| Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer | Q44880195 | ||
| Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine | Q46076481 | ||
| Role and extent of neck dissection for persistent nodal disease following chemo-radiotherapy for locally advanced head and neck cancer: how much is enough? | Q46734257 | ||
| Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study | Q47746681 | ||
| Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis. | Q53447488 | ||
| Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. | Q53540267 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1387-1393 | |
| P577 | publication date | 2010-11-04 | |
| P1433 | published in | Head & Neck | Q13703062 |
| P1476 | title | Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome | |
| P478 | volume | 33 |
| Q38217410 | Elective lymphadenectomy during salvage for locally recurrent head and neck squamous cell carcinoma after radiation |
| Q50110251 | Follow-up ultrasound of head and neck cancer |
| Q41081063 | Less may be more: nodal treatment in neck positive head neck cancer patients |
| Q42231140 | Longer survival in patients with human papillomavirus-related head and neck cancer after positive postradiation planned neck dissection. |
| Q53171946 | Management of the neck in the setting of definitive chemoradiation: is there a consensus? A GETTEC study. |
| Q50878024 | Neck dissection after chemoradiotherapy for oropharyngeal and hypopharyngeal cancer: the correlation between cervical lymph node metastasis and prognosis. |
| Q41683201 | No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression |
| Q37364313 | Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129. |
| Q57280613 | Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy |
| Q58145162 | The nodal response to chemoselection predicts the risk of recurrence following definitive chemoradiotherapy for pharyngeal cancer |
| Q38073089 | The role of neck dissection after radical chemoradiation for locally advanced head and neck cancer: should we move back?. |
| Q92110722 | Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUVmax , p16-negativity, and low nodal shrinkage |
Search more.